Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability

Amidon, 1995, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12, 413, 10.1023/A:1016212804288

Williams, 2013, Strategies to address low drug solubility in discovery and development, Pharmacol Rev, 65, 315, 10.1124/pr.112.005660

Krishnaiah, 2010, Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs, J Bioequiv Bioavailab, 2, 28

Kawabata, 2011, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications, Int J Pharm, 420, 1, 10.1016/j.ijpharm.2011.08.032

Hu, 2004, Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs, Drug Dev Ind Pharm, 30, 233, 10.1081/DDC-120030422

Costa, 2001, Modeling and comparison of dissolution profiles, Eur J Pharm Sci, 13, 123, 10.1016/S0928-0987(01)00095-1

Wagh, 2010, Biopharmaceutical classification system: scientific basis for biowaiver extensions, Int J Pharm Pharm Sci, 2, 12

Yu, 2002, Biopharmaceutics classification system: the scientific basis for biowaiver extensions, Pharm Res, 19, 921, 10.1023/A:1016473601633

Kumar, 2013, Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review, Crit Rev Ther Drug Carrier Syst, 30, 217, 10.1615/CritRevTherDrugCarrierSyst.2013005964

Onoue, 2012, Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability, Drug Metab Pharmacokinet, 27, 379, 10.2133/dmpk.DMPK-11-RG-101

Urbanetz, 2006, Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000, Eur J Pharm Sci, 28, 67, 10.1016/j.ejps.2005.12.009

Fahr, 2007, Drug delivery strategies for poorly water-soluble drugs, Expert Opin Drug Deliv, 4, 403, 10.1517/17425247.4.4.403

Pouton, 2006, Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system, Eur J Pharm Sci, 29, 278, 10.1016/j.ejps.2006.04.016

Leuenberger, 2005, Pharmaceutical powder technology-from art to science: the challenge of the FDA's process analytical technology initiative, Adv Powder Technol, 16, 3, 10.1163/1568552053166683

Davé, 2013, Special issue on pharmaceutical powders: towards developing understanding of the influence of materials and processes on product performance, Powder Technol, 236, 1, 10.1016/j.powtec.2012.09.005

Dressman, 2007, Estimating drug solubility in the gastrointestinal tract, Adv Drug Deliv Rev, 59, 591, 10.1016/j.addr.2007.05.009

Savjani, 2012, Drug solubility: importance and enhancement techniques, ISRN Pharm, 1

Leleux, 2013, Recent advancements in mechanical reduction methods: Particulate systems, Drug Dev Ind Pharm, 3109, 1

Dokoumetzidis, 2006, A century of dissolution research: from noyes and whitney to the biopharmaceutics classification system, Int J Pharm, 321, 1, 10.1016/j.ijpharm.2006.07.011

Sun, 2012, Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q(10) as naked nanocrystals, Int J Nanomed, 7, 5733

Junghanns, 2008, Nanocrystal technology, drug delivery and clinical applications, Int J Nanomed, 3, 295

Merisko-Liversidge, 2003, Nanosizing: a formulation approach for poorly-water-soluble compounds, Eur J Pharm Sci, 18, 113, 10.1016/S0928-0987(02)00251-8

Rawat, 2011, Solubility: Particle size reduction is a promising approach to improve the bioavailability of lipophillic drugs, Int J Recent Adv Pharm Res, 1, 8

Rasenack, 2004, Micron-size drug particles: common and novel micronization techniques, Pharm Dev Technol, 9, 1, 10.1081/PDT-120027417

Midoux, 1999, Micronization of pharmaceutical substances in a spiral jet mill, Powder Technol, 104, 113, 10.1016/S0032-5910(99)00052-2

Jinno, 2006, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J Control Release, 111, 56, 10.1016/j.jconrel.2005.11.013

Han, 2011, Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles, Int J Pharm, 415, 185, 10.1016/j.ijpharm.2011.05.070

Liversidge, 1995, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. absolute oral bioavailability of nanocrystalline danazol in beagle dogs, Int J Pharm, 125, 91, 10.1016/0378-5173(95)00122-Y

Graeser, 2010, The role of configurational entropy in amorphous systems, Pharmaceutics, 2, 224, 10.3390/pharmaceutics2020224

Patterson, 2007, Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling, Int J Pharm, 336, 22, 10.1016/j.ijpharm.2006.11.030

Kluge, 2012, High pressure homogenization of pharmaceutical solids, J Supercrit Fluid, 66, 380, 10.1016/j.supflu.2012.01.009

Keck, 2006, Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation, Eur J Pharm Biopharm, 62, 3, 10.1016/j.ejpb.2005.05.009

Müller, 1998, Nanosuspensions for the formulation of poorly soluble drugs: I. preparation by a size-reduction technique, Int J Pharm, 160, 229, 10.1016/S0378-5173(97)00311-6

Hecq, 2005, Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine, Int J Pharm, 299, 167, 10.1016/j.ijpharm.2005.05.014

Hu, 2003, Solubility and micronization of griseofulvin in supercritical CO2 with cosolvent acetone, Proc 6th Int Symp Supercrit Fluid

Kayrak, 2003, Micronization of ibuprofen by RESS, J Supercrit Fluid, 26, 17, 10.1016/S0896-8446(02)00248-6

Koshy, 2010, Drug particle engineering of poorly water soluble drugs, Der Pharm Let, 2, 65

Rogers, 2001, Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies, Drug Dev Ind Pharm, 27, 1003, 10.1081/DDC-100108363

Rogers, 2002, A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: Spray-freezing into liquid, Eur J Pharm Biopharm, 54, 271, 10.1016/S0939-6411(02)00063-2

Rogers, 2003, Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: Spray-freezing into liquid with atmospheric freeze-drying, Pharm Res, 20, 485, 10.1023/A:1022628826404

Hu, 2003, Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems, Eur J Pharm Sci, 20, 295, 10.1016/S0928-0987(03)00203-3

Purvis, 2006, Cryogenic liquids, nanoparticles, and microencapsulation, Int J Pharm, 324, 43, 10.1016/j.ijpharm.2006.04.012

Blagden, 2007, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Adv Drug Deliv Rev, 59, 617, 10.1016/j.addr.2007.05.011

Deerle, 2010, Particle engineering techniques to enhance dissolution of poorly water soluble drugs, Int J Cur Pharm Res, 2, 10

McNamara, 2006, Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API, Pharm Res, 23, 1888, 10.1007/s11095-006-9032-3

Sajeev Kumar, 2014, Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery, Drug Deliv, 21, 173, 10.3109/10717544.2013.840690

da Fonseca Antunes, 2013, Solvent-free drug crystal engineering for drug nano-& micro suspensions, Eur J Pharm Sci, 48, 121, 10.1016/j.ejps.2012.10.017

Tang, 2008, Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms, Drug Discov Today, 13, 606, 10.1016/j.drudis.2008.04.006

Yi, 2008, A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs, Eur J Pharm Biopharm, 70, 439, 10.1016/j.ejpb.2008.05.001

Kim, 2012, Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier, J Microencapsul, 29, 323, 10.3109/02652048.2011.651497

Balakrishnan, 2009, Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS), Eur J Pharm Biopharm, 72, 539, 10.1016/j.ejpb.2009.03.001

Chen, 2011, Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability, Biol Pharm Bull, 34, 278, 10.1248/bpb.34.278

Yan, 2011, Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique, Biol Pharm Bull, 34, 1179, 10.1248/bpb.34.1179

Agarwal, 2013, Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration, Drug Dev Ind Pharm, 39, 1681, 10.3109/03639045.2012.729594

Kanaujia, 2013, Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate, J Microencapsul, 31, 293, 10.3109/02652048.2013.843601

Kang, 2011, Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets, Drug Dev Ind Pharm, 37, 1298, 10.3109/03639045.2011.571695

Brewster, 2007, Cyclodextrins as pharmaceutical solubilizers, Adv Drug Deliv Rev, 59, 645, 10.1016/j.addr.2007.05.012

Singh, 2011, Oral formulation strategies to improve solubility of poorly water-soluble drugs, Expert Opin Drug Deliv, 8, 1361, 10.1517/17425247.2011.606808

Carrier, 2007, The utility of cyclodextrins for enhancing oral bioavailability, J Control Release, 123, 78, 10.1016/j.jconrel.2007.07.018

Rasheed, 2008, Cyclodextrins as drug carrier molecule: a review, Sci Pharm, 76, 567, 10.3797/scipharm.0808-05

Becket, 1999, Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins, Int J Pharm, 179, 65, 10.1016/S0378-5173(98)00382-2

Rawat, 2004, Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes, Eur J Pharm Biopharm, 57, 263, 10.1016/j.ejpb.2003.10.020

Memişoğlu, 2003, Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes, Pharm Res, 20, 117, 10.1023/A:1022263111961

Bader, 1984, Watersoluble polymers in medicine, Angew Makromol Chem, 123, 457, 10.1002/apmc.1984.051230121

Jones, 1999, Polymeric micelles–a new generation of colloidal drug carriers, Eur J Pharm Biopharm, 48, 101, 10.1016/S0939-6411(99)00039-9

Lukyanov, 2004, Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs, Adv Drug Deliv Rev, 56, 1273, 10.1016/j.addr.2003.12.004

Torchilin, 2004, Targeted polymeric micelles for delivery of poorly soluble drugs, Cell Mol Life Sci, 61, 2549, 10.1007/s00018-004-4153-5

Gaucher, 2005, Block copolymer micelles: preparation, characterization and application in drug delivery, J Control Release, 109, 169, 10.1016/j.jconrel.2005.09.034

Kwon, 1996, Polymeric micelles as new drug carriers, Adv Drug Deliv Rev, 21, 107, 10.1016/S0169-409X(96)00401-2

Lee, 2007, Hydrotropic polymeric micelles for enhanced paclitaxel solubility: In vitro and in vivo characterization, Biomacromolecules, 8, 202, 10.1021/bm060307b

Shin, 2009, Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs, J Control Release, 140, 294, 10.1016/j.jconrel.2009.04.024

Yu, 1998, Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B, J Control Release, 53, 131, 10.1016/S0168-3659(97)00245-9

Mohammed, 2004, Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability, Int J Pharm, 285, 23, 10.1016/j.ijpharm.2004.07.010

Zhang, 2005, Development and characterization of a novel cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation, Eur J Pharm Biopharm, 59, 177, 10.1016/j.ejpb.2004.06.009

Crowe, 1985, Preservation of freeze-dried liposomes by trehalose, Arch Biochem Biophys, 242, 240, 10.1016/0003-9861(85)90498-9

Ghanbarzadeh, 2013, The effects of lyophilization on the physico-chemical stability of sirolimus liposomes, Adv Pharm Bull, 3, 25

Yang, 2007, Liposome formulation of paclitaxel with enhanced solubility and stability, Drug Deliv, 14, 301, 10.1080/10717540601098799

Yang, 2007, Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation, Int J Pharm, 338, 317, 10.1016/j.ijpharm.2007.02.011

Üner, 2007, Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives, Int J Nanomed, 2, 289

Müller, 2000, Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art, Eur J Pharm Biopharm, 50, 161, 10.1016/S0939-6411(00)00087-4

Mehnert, 2001, Solid lipid nanoparticles: production, characterization and applications, Adv Drug Deliv Rev, 47, 165, 10.1016/S0169-409X(01)00105-3

Hu, 2004, Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs, J Pharm Pharmacol, 56, 1527, 10.1211/0022357044959

Das, 2011, Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables, Colloids Surf B Biointerfaces, 88, 483, 10.1016/j.colsurfb.2011.07.036